What Is a 510(k)? FDA Clearance for Medical Devices Explained

2026-09-26 · Caduvo Team

A 510(k) is the most common medical device submission to FDA, but its mechanics are often misunderstood. Here's how substantial equivalence works, what goes into a submission, real timelines, and the pitfalls that trigger Additional Information requests.

Every device company’s first real brush with the FDA usually starts with a question: Do we need a 510(k)? If you’re building a product that touches patients, getting the answer right shapes your entire regulatory timeline—and your funding runway.

A 510(k) premarket notification is the pathway that demonstrates a new device is “substantially equivalent” to a legally marketed device (the predicate). Substantial equivalence means same intended use and similar technological characteristics. If the FDA agrees, your device is cleared, not approved. Cleared means it’s comparable to something already on the market; approved is reserved for the PMA process that proves safety and effectiveness independently. That distinction matters every time you talk to investors, providers, and payers.

Who Needs a 510(k) and Who Doesn’t

For most class II devices and a handful of class I and class III devices, a 510(k) is required before you can sell in the U.S. Your first job is to confirm the FDA product code and classification. Start with the FDA medical device classification database, which tells you whether a 510(k) is generally required for that product type.

• Class I devices – Most are 510(k)-exempt unless they fall into a small subset (like some surgical instruments).
• Class II devices – The vast majority need 510(k) clearance. Exempt class II devices exist (certain dental chairs, for example) but are the exception.
• Class III devices – Generally need a PMA, but some pre-amendments class III devices still have a 510(k) route until the FDA mandates a PMA.

If no suitable predicate exists—meaning you can’t find a marketed device with the same intended use and similar technology—you can’t use a 510(k). A novel, low-to-moderate risk device would then go through the De Novo pathway. Comparing 510(k) vs PMA vs De Novo maps out which door to knock on.

What You Actually Put in a 510(k) Submission

A 510(k) isn’t a form. It’s a structured package of evidence. Since October 2023, the FDA requires the eSTAR (Electronic Submission Template And Resource) for all 510(k)s, which acts as a guided questionnaire and then produces a finalized PDF. eSTAR enforces consistency, but you still need to know what goes where.

At minimum, a submission contains:

1. Cover letter and administrative forms – Contact info, 510(k) owner, intended use statement.
2. Indications for Use form (Form FDA 3881) – The exact wording that will appear on your clearance letter. Every word counts.
3. 510(k) Summary or 510(k) Statement – A summary becomes public upon clearance; a statement certifies you’ll provide data upon request. Startups almost always use a Summary for transparency with investors and customers.
4. Substantial equivalence comparison – A side-by-side table mapping your device to the predicate: materials, dimensions, energy source, software algorithms, sterility method, labeled warnings, etc. Any difference requires a justification for why it doesn’t raise new questions of safety or effectiveness.
5. Device description – Detailed specs, functional diagrams, and operating principles.
6. Performance testing – Bench, biocompatibility (ISO 10993), electrical safety (IEC 60601), software documentation (IEC 62304), EMC, sterilization validation, shelf-life, and animal or cadaver data if needed. Clinical data is rare but not unheard of.
7. Labeling – Draft package insert, instructions for use, training materials, and any promotional claims that could trip a false “new intended use” flag.

Plan for 60 to 200 pages once you include testing reports and attachments. If the device contains software, the documentation requirements expand significantly with the FDA’s Content of Premarket Submissions for Software guidance.

Timelines and Costs: Real-World Numbers

When the FDA receives your 510(k), the clock starts. By regulation, it has 90 days to reach a decision. That’s 90 “FDA review days,” not calendar days. A Refuse to Accept (RTA) hold stops the clock; an Additional Information (AI) request stops the clock until you respond.

In practice, a smooth 510(k) takes 5 to 8 months from submission date to clearance letter. A submission that draws an AI request will stretch to 10–14 months or longer, depending on response quality.

User fees (FY2024):

• Standard 510(k): $21,760
• Small business (FDA-qualified Small Business Determination): $5,440

The internal and external costs to prepare the submission are separate. Depending on the complexity and testing needed, expect to spend:

• Testing and reports (biocompatibility, electrical safety, software validation): $30,000–$120,000
• Regulatory consultant support (if you don’t have in-house expertise): $25,000–$80,000
• Internal team time (drafting, project management, quality system documentation): 3–6 months of dedicated effort

A clean, well-prepped 510(k) for a simple class II device can come in under $80,000 all-in. A software-driven device with sterile claims and complex bench testing can push $200,000+.

Why the FDA Sends AI Requests (and How to Avoid Them)

AI requests delay clearance, consume resources, and rattle boards. Most trace back to predictable gaps:

• Inadequate predicate comparison – Handwaving a difference as “minor” without objective evidence. If a dimension, material, or output differs, tie it to accepted test standards or published rationale. Selecting a predicate device that won’t get held up reduces this risk at the front end.
• Missing or incomplete performance testing – Forgetting a required standard (e.g., biocompatibility for devices contacting mucosal tissue, or software documentation for a SaMD). Follow FDA guidance documents for your device type; don’t assume what was enough for a competitor five years ago still applies.
• Labeling mismatches – The indications for use statement in the 510(k) summary doesn’t exactly match Form 3881. Or the device labeling includes an implied use that goes beyond what the predicate covered, triggering a “new intended use” finding.
• Unaddressed FDA guidance – If the FDA recognizes a final guidance for your device type and your submission doesn’t address its recommendations, reviewers will ask why.
• Relying solely on equivalence without comparative data – When a predicate is old and its original performance data isn’t available, you may need to generate new verification data, not just a side-by-side description.

Actionable Takeaways

• Confirm your FDA product code and classification first. A 510(k) is only useful if a predicate exists; otherwise, map your De Novo or PMA options early.
• Lock in your predicate device and build the substantial equivalence comparison as a living document, not an afterthought.
• Use the FDA eSTAR template. It reduces formatting rejections and flags missing sections before submission.
• Budget 5–8 months for a clean review, and at least 12 months if you get an AI request. Don’t promise investors a clearance date.
• Call the result “clearance,” never “approval.” Losing that battle in pitching docs or marketing copy invites FDA enforcement.

FDA clearance is a gate, not the finish line. The same submission that gets you a 510(k) letter is the evidence pack you’ll need to explain to payers and hospitals why your device deserves a code and a spot on the shelf.